SODIUM 2,5-DICHLORO-4-(4,5-DIHYDRO-3-METHYL-4-((4-((P-TOLYLSULFONYL)OXY)PHENYL)AZO)-5-OXO-1H-PYRAZOL-1-YL)BENZENESULFONATE
UNII 7VC1639243
Substance Identification & Data
This profile provides standardized clinical and technical data for Sodium 2,5-dichloro-4-(4,5-dihydro-3-methyl-4-((4-((p-tolylsulfonyl)oxy)phenyl)azo)-5-oxo-1h-pyrazol-1-yl)benzenesulfonate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 7VC1639243.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 67923-65-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C23H17Cl2N4O7S2.Na SVRNLEXUWOHUNU-JGUILPGDSA-M Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Sodium 2,5-dichloro-4-(4,5-dihydro-3-methyl-4-((4-((p-tolylsulfonyl)oxy)phenyl)azo)-5-oxo-1h-pyrazol-1-yl)benzenesulfonate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.